Rojo, Pablo
Moraleda, Cinta
Tagarro, Alfredo http://orcid.org/0000-0003-2860-3455
Domínguez-Rodríguez, Sara
Castillo, Lola Madrid
Tato, Luis Manuel Prieto
López, Aranzazu Sancho
Manukyan, Lilit
Marcy, Olivier
Leroy, Valeriane
Nardone, Alessandra
Burger, David
Bassat, Quique
Bates, Matthew
Moh, Raoul
Iroh Tam, Pui-Ying
Mvalo, Tisungane
Magallhaes, Justina
Buck, W. Chris
Sacarlal, Jahit
Musiime, Victor
Chabala, Chishala
Mujuru, Hilda Angela
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (RIA2017MC-2013 EMPIRICAL)
Article History
Received: 6 September 2021
Accepted: 26 March 2022
First Online: 27 June 2022
Declarations
:
: The trial has been approved by the Investigation Ethics Committee of Medicines (CEIm) N°CEIm: 19/096 Hospital ¨12 de Octubre on March 13 2019¨and by all the enrolling sites’ Ethical Boards and Regulatory Agencies.Written, informed consent to participate will be obtained from all participants’ caregivers.
: Not applicable.
: The authors declare that they have no competing interests.